Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Circius Pharma AB
AB
Active
Org 5592313927
Södra Långebergsgatan 34-36, 436 32
Askim
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2019 · 6 years old
13 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Circius Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
179M
134M
90M
45M
0M
2020: 0M
0M
2020
2021: 27M
27M
2021
2022: 103M (+281% vs 2021)
103M
+281%
2022
2023: 144M (+40% vs 2022)
144M
+40%
2023
2024: 113M (-22% vs 2023)
113M
-22%
2024
EBITDA
SEK millions
21M
12M
4M
-4M
-13M
2020: 0M
0M
2020
2021: -6M
-6M
2021
2022: 5M (+183% vs 2021)
5M
+183%
2022
2023: 14M (+180% vs 2022)
14M
+180%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
112 570
143 953
103 035
27 296
0
Staff expenses
—
—
—
—
—
EBITDA
190
14 458
4 727
−5 526
−2
Depreciation & amort.
−2 805
−2 801
−2 637
−1 307
−0
EBIT
−2 615
11 657
2 090
−6 833
−2
Net financials
2 781
−3 032
472
103 548
301 562
Profit before tax
166
6 433
2 563
96 715
77 249
Tax
−92
−1 826
−0
−0
−0
Net profit
74
4 607
2 563
96 715
77 249
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
153 147
152 702
135 823
241 944
124 299
Equity
128 258
128 183
123 576
221 013
124 299
Long-term debt
0
0
0
627
0
Short-term debt
22 589
22 218
12 247
20 304
0
Total debt
22 589
22 218
12 247
20 931
—
Financial ratios
5-year trend
EBITDA margin
0,2 %
This company
15,8 %
Market median
This company
Market median
99% below market
2020
2024
Equity ratio
83,7 %
This company
38,2 %
Market median
This company
Market median
119% above market
2020
2024
Return on equity
0,1 %
This company
18,4 %
Market median
This company
Market median
99% below market
2020
2024
Net profit margin
0,1 %
This company
8,1 %
Market median
This company
Market median
99% below market
2020
2024
Asset turnover
0,74×
This company
1,12×
Market median
This company
Market median
34% below market
2020
2024
Debt / equity
0,19×
This company
0,62×
Market median
This company
Market median
69% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
View
PDF
More on Circius Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
